A Randomized, Multicenter, Double-Blind, Double Dummy, Active Comparator, Dose-Ranging Study to Explore the Efficacy of SUBSYS® in Emergency Department Patients With Acute Pain
Status: Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 07 Jul 2017
Price : $35 *
At a glance
- Drugs Fentanyl (Primary) ; Morphine
- Indications Acute pain
- Focus Therapeutic Use
- Sponsors INSYS Therapeutics, Inc
- 29 Jun 2017 Planned initiation date changed from 30 Jun 2017 to 31 Jul 2017.
- 27 Oct 2016 Planned End Date changed from 1 Nov 2017 to 1 Dec 2017.
- 27 Oct 2016 Planned primary completion date changed from 1 Apr 2017 to 1 Dec 2017.